Gobi Acquisition Corp. (GOBI) Stock Analysis
DELISTED 2022
What happened to Gobi Acquisition Corp. (GOBI) stock?
Gobi Acquisition Corp. (GOBI) no longer trades on public markets. It was delisted in July 2022. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Gobi Acquisition Corp. (GOBI) trades at $10.00. Gobi Acquisition Corp. is a shell company based in Hong Kong, focused on merging with or acquiring a business in the healthcare or related industries. Sector: Financial services.
Last analyzed: Mar 17, 2026Analyst Coverage for GOBI: GOBI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GOBI against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Gobi Acquisition Corp. (GOBI) Financial Services Profile
Gobi Acquisition Corp., a Hong Kong-based shell company incorporated in 2021, is actively seeking a merger, asset acquisition, or similar business combination within the healthcare sector. Currently without significant operations, GOBI represents a speculative investment opportunity tied to its future acquisition target in the healthcare industry.
What Is the Investment Thesis for GOBI?
Gobi Acquisition Corp. presents a speculative investment opportunity centered on its ability to identify and acquire a target company within the healthcare sector. As of March 2026, GOBI's value is tied to the potential of a future merger or acquisition. A key value driver is the management team's expertise in sourcing and negotiating deals. Successful acquisition of a high-growth healthcare company could lead to significant returns for investors. However, the investment is subject to risks including failure to find a suitable target, unfavorable acquisition terms, or poor performance of the acquired company. The negative P/E ratio of -386.13 reflects the current lack of operational earnings.
Based on FMP financials and quantitative analysis
GOBI Key Highlights
Gobi Acquisition Corp. was incorporated in 2021, indicating its relatively recent establishment as a SPAC.
- The company's focus is on the healthcare or healthcare-related industries, signaling its strategic investment direction.
- Gobi Acquisition Corp. is based in Hong Kong, which may present unique regulatory and geopolitical considerations.
- The company currently has no significant operations, highlighting its status as a shell company awaiting a business combination.
- The negative P/E ratio of -386.13 reflects the current lack of operational earnings, underscoring the speculative nature of the investment.
Who Are GOBI's Competitors?
GOBI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AFTR AfterNext HealthTech Acquisition Corp. | $10.41 | -0.01% | $325M | 44 |
| ATVC Tribe Capital Growth Corp I | $9.81 | +0.10% | $338M | 44 |
| HWEL Healthwell Acquisition Corp. I | $10.47 | +0.05% | $327M | 44 |
| HZON Horizon Acquisition Corporation II | $11.32 | +0.09% | $344M | 46 |
| AGGI Allied Energy, Inc. | $2.25 | +32.24% | $45.4B | 61 |
| GSHN Gushen, Inc. | $22.70 | +2.71% | $9.32B | 61 |
| IVAN Ivanhoe Capital Acquisition Corp. | $7.68 | -2.17% | $2.69B | 64 |
| APXTW Apex Treasury Corporation | $0.37 | +0.00% | $1.99B | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GOBI's Key Strengths?
Dedicated focus on the healthcare sector.
- Experienced management team with deal-making expertise.
- Access to capital raised through the IPO.
- Flexibility to pursue various types of business combinations.
What Are GOBI's Weaknesses?
Lack of current operations and revenue.
- Dependence on identifying and acquiring a suitable target.
- Potential for shareholder dilution through equity issuances.
- Competition from other SPACs seeking acquisitions.
What Could Drive GOBI Stock Higher?
Announcement of a definitive agreement to acquire a target company in the healthcare sector.
- Progress in negotiations with potential acquisition targets.
- Favorable developments in the healthcare industry, such as new drug approvals or technological breakthroughs.
What Are the Key Risks for GOBI?
Failure to identify and acquire a suitable target within the specified timeframe.
- Unfavorable market conditions or regulatory changes impacting the healthcare sector.
- Dilution of shareholder value through future equity issuances.
- Competition from other SPACs seeking acquisitions in the same industry.
What Are the Growth Opportunities for GOBI?
- Successful Acquisition: Gobi's primary growth opportunity lies in successfully acquiring a high-growth potential company within the healthcare sector. The timeline for this growth is dependent on the company's ability to identify, negotiate, and close a deal, which could occur within the next 12-24 months. A well-chosen acquisition could provide significant returns for investors.
- Geographic Expansion: Once a target is acquired, Gobi can explore geographic expansion opportunities, particularly within Asia, leveraging its Hong Kong base. The Asian healthcare market is experiencing rapid growth, driven by increasing affluence and demand for quality healthcare services. The timeline for this expansion would likely follow the initial acquisition and integration phase, potentially commencing within 2-3 years. This expansion could unlock new revenue streams and market share.
- Technological Integration: Integrating advanced technologies, such as AI and telemedicine, into the acquired company's operations can drive efficiency and improve patient outcomes. The market for AI in healthcare is projected to grow significantly in the coming years. The timeline for this integration would depend on the nature of the acquired company and its existing technological capabilities, but could begin within 1-2 years. This integration could enhance the company's competitive advantage and attract further investment.
- Strategic Partnerships: Forming strategic partnerships with established healthcare providers, research institutions, or pharmaceutical companies can accelerate growth and expand market reach. These partnerships can provide access to new technologies, distribution channels, and expertise. The timeline for establishing these partnerships would depend on the specific opportunities identified, but could occur within the next 12-18 months. These partnerships could create synergies and drive innovation.
- Regulatory Navigation: Successfully navigating the complex regulatory landscape of the healthcare industry is crucial for growth. This includes obtaining necessary approvals for new products and services, complying with data privacy regulations, and adapting to evolving healthcare policies. The timeline for this is ongoing and requires continuous monitoring and adaptation. Effective regulatory navigation can ensure compliance and facilitate market access.
What Threats Does GOBI Face?
- Failure to find a suitable acquisition target.
- Unfavorable acquisition terms and valuation.
- Poor performance of the acquired company.
- Changes in regulatory environment or market conditions.
What Are GOBI's Competitive Advantages?
- Gobi Acquisition Corp.'s moat, if any, is dependent on the expertise and network of its management team.
- A strong management team can provide a competitive advantage in sourcing and negotiating deals.
- Access to capital and a favorable market environment can also contribute to its competitive position.
What Does GOBI Do?
Gobi Acquisition Corp. was incorporated in 2021 and is based in Hong Kong. The company currently has no significant operations and was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Gobi Acquisition Corp. intends to focus its search on target businesses operating in the healthcare or healthcare-related industries. As a special purpose acquisition company (SPAC), its value is primarily derived from its ability to identify and successfully acquire a promising healthcare company, offering investors exposure to that future entity. The company's success is contingent on its management team's expertise in identifying and negotiating favorable terms for an acquisition target within the competitive healthcare landscape. The company's future direction and performance are entirely dependent on the nature and success of its eventual acquisition.
What Products and Services Does GOBI Offer?
- Gobi Acquisition Corp. is a special purpose acquisition company (SPAC).
- It focuses on identifying and acquiring a target company.
- The company's primary objective is to effect a merger or similar business combination.
- Gobi intends to target businesses in the healthcare or healthcare-related industries.
- It seeks to provide investors with exposure to a private company going public.
- The company's operations are currently limited to searching for an acquisition target.
How Does GOBI Make Money?
- Gobi Acquisition Corp. raises capital through an initial public offering (IPO).
- The raised capital is held in a trust account and used to acquire a target company.
- The company generates revenue through fees and potential appreciation in the value of the acquired company.
- The sponsors of the SPAC typically receive equity in the combined company as compensation for their efforts.
What Industry Does GOBI Operate In?
Gobi Acquisition Corp. operates within the shell company industry, specifically as a special purpose acquisition company (SPAC). SPACs have become a popular method for private companies to go public, offering a faster and potentially less regulated alternative to traditional IPOs. The industry is characterized by intense competition among SPACs seeking attractive acquisition targets. The healthcare sector, which Gobi is targeting, is a large and rapidly evolving market, driven by technological advancements, aging populations, and increasing healthcare spending. The success of Gobi depends on its ability to differentiate itself and secure a compelling target in this competitive landscape.
Who Are GOBI's Key Customers?
- Gobi Acquisition Corp.'s primary customers are its investors who purchase shares in the IPO.
- The company also serves as a vehicle for a private healthcare company to go public.
- The ultimate beneficiaries are the shareholders of the combined public company.
Insider Activity
The most recent 6 insider filings for Gobi Acquisition Corp. break down as 3 sales and 3 purchases. On net that is roughly 59.2M shares acquired (about $12000000.0B) — insiders putting money in tends to read as conviction.
Key Financial Metrics
Return on equity for Gobi Acquisition Corp. stands at 59.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -66.7%, showing how much profit it generates from its asset base. A current ratio of 1.02 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -0.3%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Gobi Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Hong Kong, HK. The company is led by CEO Jack Zheng Li. GOBI has traded publicly since 2021.
GOBI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Dedicated focus on the healthcare sector.
- Experienced management team with deal-making expertise.
- Access to capital raised through the IPO.
- Flexibility to pursue various types of business combinations.
Bear Case
- Lack of current operations and revenue.
- Dependence on identifying and acquiring a suitable target.
- Potential for shareholder dilution through equity issuances.
- Competition from other SPACs seeking acquisitions.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
GOBI Latest News
No recent news available for GOBI.
Classification
Industry Shell CompaniesLeadership: Jack Zheng Li
CEO
Jack Zheng Li serves as the Chief Executive Officer of Gobi Acquisition Corp. His background includes experience in finance and investment management, with a focus on identifying and evaluating potential investment opportunities. He has a track record of working with companies in various stages of development, from early-stage startups to established enterprises. His expertise lies in deal structuring, financial analysis, and strategic planning. He is responsible for leading the company's efforts to find and acquire a suitable target within the healthcare sector.
Track Record: Under Jack Zheng Li's leadership, Gobi Acquisition Corp. has been actively searching for a merger or acquisition target within the healthcare industry. While the company has not yet completed a transaction, his focus has been on identifying companies with strong growth potential and innovative technologies. His strategic decisions are centered around maximizing shareholder value through a successful business combination. He is focused on navigating the competitive landscape of the SPAC market.
Gobi Acquisition Corp. Financial Services Stock: Key Questions Answered
What happened to Gobi Acquisition Corp. (GOBI) stock?
Gobi Acquisition Corp. (GOBI) no longer trades on public markets. It was delisted in July 2022. The figures below are historical and are not a current quote.
Can I still buy GOBI shares?
No. GOBI stopped trading on public markets in July 2022, so the shares are not available through a broker. Anything you see quoted for GOBI elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before GOBI stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Gobi Acquisition Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Gobi Acquisition Corp. do?
Gobi Acquisition Corp. is a special purpose acquisition company (SPAC) that was created to identify and acquire a company within the healthcare industry. It does not have any current operations.
What do analysts say about GOBI stock?
As of March 2026, there is limited analyst coverage on GOBI stock due to its status as a SPAC without current operations. The stock's performance is largely driven by speculation surrounding potential acquisition targets and the management team's ability to execute a successful deal.
What are the main risks for GOBI?
The main risks for GOBI include the failure to identify and acquire a suitable target company within the specified timeframe, which could lead to the liquidation of the SPAC and a loss of investment for shareholders.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The information provided is based on publicly available sources and current market conditions.
- The analysis is subject to change based on future developments and new information.